Cardiovascular Disorders as a Result of COVID-19

Kovalevskaiia, L.; Pakhlevanzade, A.; Ivanchenko, S.; Kupriianova, L.; Volianska, V.; Plakida, A.; Panigrahi, P.

dc.contributor.author	Kovalevskaiia, L.	en
dc.contributor.author	Pakhlevanzade, A.	en
dc.contributor.author	Ivanchenko, S.	en
dc.contributor.author	Kupriianova, L.	en
dc.contributor.author	Volianska, V.	en
dc.contributor.author	Plakida, A.	en
dc.contributor.author	Panigrahi, P.	en
dc.date.accessioned	2022-10-25T08:18:55Z
dc.date.available	2022-10-25T08:18:55Z
dc.date.issued	2022
dc.identifier.citation	Kovalevskaiia L, Pakhlevanzade A, Ivanchenko S, Kupriianova L, Volianska V, Plakida A, Panigrahi P. Cardiovascular Disorders as a Result of COVID-19. Open Access Maced J Med Sci. 2022 Aug 18; 10(B):1862-1868.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/11579
dc.description.abstract	Based on the literature data, we present current literature information about frequency, main spectrum, and prognostic value of cardiovascular complications of the SARS-CoV-2 infection. We have highlighted in detail the variants of cardiovascular disorders in the case of patients with SARS-CoV-2 infection caused by concomitant diseases of hypertension, acute coronary syndrome, myocardial infarction, arrhythmias, virus-associated myocarditis, and heart failure. We have described the adverse cardiovascular effects of medicines of different groups used to treat COVID-19 disease and possible medical interactions. We have summarized some current recommendations on cardiotonic and cardioprotective therapy in the case of patients with cardiovascular complications.	en
dc.language.iso	en	en
dc.subject	COVID-19	en
dc.subject	Cardiovascular complications	en
dc.subject	Myocardial damage	en
dc.title	Cardiovascular Disorders as a Result of COVID-19	en
dc.type	Article	en